Pfizer, BioNTech announce agreement with UK for 30 million doses of mRNA-based vaccine candidate against SARS-CoV-2

Pfizer and BioNTech have announced agreement with UK for 30 million doses of mRNA-based vaccine candidate against SARS-CoV-2. (Credit: Gerd Altmann from Pixabay)